Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00508287 · ClinicalTrials.gov registry record · Phase 1

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes

A Phase 1 study of Type 2 Diabetes, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 1
Development phase
36
Enrollment target
3
Study locations

NCT00508287 is a Phase 1 study of Type 2 Diabetes that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 36 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00508287, a Phase 1 study of Type 2 Diabetes, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 1
Development phase
36 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of single doses of BMS-686117

Conditions Studied

Type 2 Diabetes

Interventions

  • DRUG Placebo
  • DRUG BMS-686117
  • DRUG Byetta

Study Locations (3)

Florida

  • Elite Research Institute - Miami
  • Orlando Clinical Research Center - Orlando

Tennessee

  • New Orleans Center For Clinical Research - Knoxville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2007-08
Est. Completion 2007-11
Phase Phase 1

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00508287

The ClinicalTrials.gov registry entry for NCT00508287 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00508287 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Tennessee.

Frequently Asked Questions

What is clinical trial NCT00508287 about?

NCT00508287 is a clinical study titled "Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes". The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of single doses of BMS-686117

What is the current status of trial NCT00508287?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2007-08. Estimated completion is 2007-11.

What conditions does trial NCT00508287 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT00508287?

The interventions under investigation include: Placebo (DRUG), BMS-686117 (DRUG), Byetta (DRUG).

Who is sponsoring clinical trial NCT00508287?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00508287 being conducted?

This trial has 3 study locations across Florida, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.